Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Nioxin scalp recovery medicating cleanser - Medication Information

Product NDC Code 69282-007
Drug Name

Nioxin scalp recovery medicating cleanser

Type Brand
Active Ingredients
Pyrithione zinc .5 g/100ml
Route TOPICAL
Dosage Form LOTION
RxCUI drug identifier 1043014,
1593569
Application Number part358H
Labeler Name The Wella Corporation
Packages
Package NDC Code Description
69282-007-10 1000 ml in 1 bottle, plastic (69282-007-10)
69282-007-20 200 ml in 1 bottle, plastic (69282-007-20)
69282-007-50 1 bottle, plastic in 1 carton (69282-007-50) / 50 ml in 1 bottle, plastic
Check if available Online

Active ingredient

A list of the active, medicinal ingredients in the drug product.
Active ingredient Pyrithione Zinc 0.5%

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
Directions For best results use at least twice a week or as directed by a doctor. Use daily for maximum dandruff control. Massage on to wet scalp and hair. Rinse. Repeat if desired.

Inactive ingredient

A list of inactive, non-medicinal ingredients in a drug product.
Inactive ingredients WATER, STEARYL ALCOHOL, CETYL ALCOHOL, STEARAMIDOPROPYL DIMETHYLAMINE, DIMETHICONE, GLUTAMIC ACID, BENZYL ALCOHOL, PHENOXYETHANOL, FRAGRANCE, PROPYLPARABEN, METHYLPARABEN, CITRIC ACID, MENTHA PIPERITA (PEPPERMINT) OIL, MENTHA ARVENSIS LEAF OIL, MENTHOL, YEAST EXTRACT, CAMELLIA SINENSIS LEAF EXTRACT, LECITHIN, PPG-26-BUTETH-26, SACCHAROMYCES/MAGNESIUM FERMENT, DIMETHYL ISOSORBIDE, PEG/PPG-18/18 DIMETHICONE, ETHOXYDIGLYCOL, CARNITINE HCL, ORYZA SATIVA (RICE) BRAN, PEG-40 HYDROGENATED CASTOR OIL, BIOTIN/FOLIC ACID/CYANOCOBALAMIN/NIACINAMIDE/PANTOTHENIC ACID/PYRIDOXINE/RIBOFLAVIN/THIAMINE/YEAST POLYPEPTIDES, SACCHAROMYCES/IRON FERMENT, SACCHAROMYCES/COPPER FERMENT, SACCHAROMYCES/SILICON FERMENT, SACCHAROMYCES/ZINC FERMENT, ACACIA SENEGAL GUM, UBIQUINONE.

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
Uses helps prevent recurrence of flaking and itching associated with dandruff.

Purpose

Information about the drug product’s indications for use.
Purpose Anti-dandruff

Spl product data elements

Usually a list of ingredients in a drug product.
Nioxin Scalp Recovery Medicating Cleanser Pyrithione Zinc WATER STEARYL ALCOHOL CETYL ALCOHOL STEARAMIDOPROPYL DIMETHYLAMINE DIMETHICONE GLUTAMIC ACID BENZYL ALCOHOL PHENOXYETHANOL PROPYLPARABEN METHYLPARABEN CITRIC ACID MONOHYDRATE PEPPERMINT OIL MENTHA ARVENSIS LEAF OIL MENTHOL, UNSPECIFIED FORM YEAST, UNSPECIFIED GREEN TEA LEAF PPG-26-BUTETH-26 DIMETHYL ISOSORBIDE PEG/PPG-18/18 DIMETHICONE DIETHYLENE GLYCOL MONOETHYL ETHER LEVOCARNITINE HYDROCHLORIDE RICE BRAN POLYOXYL 40 HYDROGENATED CASTOR OIL ACACIA UBIDECARENONE PYRITHIONE ZINC PYRITHIONE ZINC

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
PRINCIPAL DISPLAY PANEL - 200 mL Bottle Label NIOXIN ® SCALP RECOVERY ® For a dry, itchy scalp PYRITHIONE ZINC DANDRUFF CONDITIONER MOISTURIZING CONDITIONER 100% FLAKE FREE ELIMINATION OF VISIBLE FLAKES WITH REGULAR USE* 99864275 200 mL (6.76 FL OZ) Principal Display Panel - 200 mL Bottle Label

Spl unclassified section

Information not classified as belonging to one of the other fields. Approximately 40% of labeling with effective_time between June 2009 and August 2014 have information in this field.
Drug Facts Dist. by THE WELLA CORPORATION, WOODLAND HILLS, CA 91367

Keep out of reach of children

Information pertaining to whether the product should be kept out of the reach of children, and instructions about what to do in the case of accidental contact or ingestion, if appropriate.
Keep this and all drugs out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Questions

A telephone number of a source to answer questions about a drug product. Sometimes available days and times are also noted.
Questions? 1-800-935-5273

Stop use

Information about when use of the drug product should be discontinued immediately and a doctor consulted. Includes information about any signs of toxicity or other reactions that would necessitate immediately discontinuing use of the product.
Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed.

When using

Information about side effects that people may experience, and the substances (e.g. alcohol) or activities (e.g. operating machinery, driving a car) to avoid while using the drug product.
When using this product avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water.

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
Warnings For external use only. When using this product avoid contact with eyes. If contact occurs, rinse eyes thoroughly with water. Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed. Keep this and all drugs out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API